US Stock MarketDetailed Quotes

FBIN Fortune Brands Innovations

Watchlist
  • 64.720
  • -0.250-0.38%
Close Feb 28 16:00 ET
  • 64.610
  • -0.110-0.17%
Post 20:01 ET
7.93BMarket Cap17.26P/E (TTM)

Fortune Brands Innovations Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Fortune Brands Innovations Q4 2024 Earnings Date

Currency：USDFeb 6, 2025

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
1.15B
1.10B
-41.57M
Miss Est.
-1.34%
-4.92%
-3.63%
EPS
1.05
0.84
-0.21
Miss Est.
+64.28%
+31.25%
-20.11%
Analyst Rating
Buy

Feb 28, 2025

Fortune Brands Innovations Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 15 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 1.247B--
--2025/Q1-- / 1.069B--
Feb 6, 20252024/Q41.104B / 1.146B--
Nov 6, 20242024/Q31.155B / 1.242B--
Jul 25, 20242024/Q21.240B / 1.280B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 1.247B--
--2025/Q1-- / 1.069B--
Feb 6, 20252024/Q41.104B / 1.146B--
Nov 6, 20242024/Q31.155B / 1.242B--
Jul 25, 20242024/Q21.240B / 1.280B--

Unlock Free Earnings Estimates

Fortune Brands Innovations Earnings Reports

  • Fortune Brands Innovations | 10-K: FY2024 Annual Report

    Feb 25 16:39 ET

  • Fortune Brands Innovations | 10-Q: Q3 2024 Earnings Report

    Nov 7, 2024 13:23 ET

  • Fortune Brands Innovations | 10-Q: Q2 2024 Earnings Report

    Jul 26, 2024 16:24 ET

  • Fortune Brands Innovations | 10-Q: Q1 2024 Earnings Report

    May 1, 2024 16:14 ET

    • Read more

    Trending Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    Cars.com
    CARS
    +9.73%
    Lantheus
    LNTH
    +2.55%
    Halozyme Therapeutics
    HALO
    +2.51%
    DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
    DMZPY
    +2.27%
    Collegium Pharmaceutical
    COLL
    +2.22%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Feb 28, 2025

    Buy

    • Buy

      41.67%

    • Hold

      50.00%

    • Sell

      8.33%

    Price Target

    No Data